共 10 条
[1]
Chapman R., Fevery J., Kalloo A., Nagorney D.M., Boberg K.M., Shneider B., Et al., Primary sclerosing cholangitis, Hepatology, 51, pp. 660-678, (2010)
[2]
Fraile G., Rodriguez-Garcia J.L., Moreno A., Primary sclerosing cholangitis associated with systemic sclerosis, Postgrad Med J, 67, pp. 189-192, (1991)
[3]
Abraham S., Begum S., Isenberg D., Hepatic manifestations of autoimmune rheumatic diseases, Ann Rheum Dis, 63, pp. 123-129, (2004)
[4]
Murray-Lyon I.M., Thompson R.P.H., Ansell I.D., Williams R., Scleroderma and primary biliary cirrhosis, BMJ, 3, pp. 258-259, (1970)
[5]
Fattinger K., Funk C., Pantze M., Weber C., Reichen J., Stieger B., Et al., The endothelin antagonist bosentan inhibits the canalicular bile salt export pump: A potential mechanism for hepatic adverse reactions, Clin Pharmacol Ther, 69, pp. 223-231, (2001)
[6]
Treiber A., Aanismaa P., De Kanter R., Delahaye S., Treher M., Hess P., Et al., Macitentan does not interfere with hepatic bile salt transport, J Pharmacol Exp Ther, 350, pp. 130-143, (2014)
[7]
Yimam K.K., Bowlus C.L., Diagnosis and classification of primary sclerosing cholangitis, Autoimmun Rev, 13, pp. 445-450, (2014)
[8]
Dave M., Elmunzer B.J., Dwamena B.A., Higgins P.D., Primary sclerosing cholangitis: A meta-analysis of diagnostic performance of MR cholangiopancreatography, Radiology, 256, (2010)
[9]
Kumagi T., Heathcote E.J., Primary biliary cirrhosis, Orphanet J Rare Dis, 3, pp. 1-17, (2008)
[10]
Chapman R., Fevery J., Kalloo A., Nagorney D.M., Boberg K.M., Shneider B., Et al., Diagnosis and management of primary sclerosing cholangitis, Hepatology, 51, pp. 660-678, (2010)